<[link removed]>CDC Establishes New Workgroup to Study the Safety of Aluminum in Childhood Vaccines

By James Lyons-Weiler, Science and Medicine Contributor,The MAHA Report <[link removed]>

The U.S. Centers for Disease Control and Prevention (CDC), through its Advisory Committee on Immunization Practices (ACIP), has established the Childhood and Adolescent Immunization Schedule Workgroup with a mandate to study aluminum adjuvants – salts – in some vaccines given to children.

<[link removed]>As of October 8, 2025, CDC’s newly revised Terms of Reference (ToR) <[link removed]> include ingredient-specific safety evaluations, with a direct focus on aluminum adjuvants and associated risks, including asthma.

The updated Terms of Reference asks: “Do either of the two different aluminum adjuvants increase the risk of asthma?” This language marks the first formal acknowledgment by ACIP that aluminum hydroxide and aluminum phosphate, the primary adjuvants in most pediatric vaccines, may merit differentiated toxicological scrutiny. This change places the issue within the Workgroup’s formal priority and scope, not as a fringe or side issue.

<[link removed]>KEEP READING <[link removed]> <[link removed]>

Make America Healthy Again™ and MAHA™ are trademarks owned by MAHA TM LLC © 2025 MAHA Action. All rights reserved.  307 W 36th St, 11FL, New York, NY 10018, United States

This email was sent to [email protected] · Unsubscribe <[link removed]>

Privacy Policy <[link removed]> • Terms of Use <[link removed]> • Contact Us <[link removed]>

<[link removed]> <[link removed]> <[link removed]>